These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8735716)

  • 21. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas.
    Akita M; Fujikura K; Ajiki T; Fukumoto T; Otani K; Azuma T; Itoh T; Ku Y; Zen Y
    Mod Pathol; 2017 Jul; 30(7):986-997. PubMed ID: 28338651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A; Wittekind C
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
    Zimmerman RL; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression.
    Yu TH; Yuan RH; Chen YL; Yang WC; Hsu HC; Jeng YM
    Mod Pathol; 2011 Jun; 24(6):810-9. PubMed ID: 21423153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 but not bcl-2 is expressed by most cholangiocarcinomas: a study of 28 cases.
    Arora DS; Ramsdale J; Lodge JP; Wyatt JI
    Histopathology; 1999 Jun; 34(6):497-501. PubMed ID: 10383693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apical membrane expression of distinct sulfated glycans represents a novel marker of cholangiolocellular carcinoma.
    Hoshino H; Ohta M; Ito M; Uchimura K; Sakai Y; Uehara T; Low S; Fukushima M; Kobayashi M
    Lab Invest; 2016 Dec; 96(12):1246-1255. PubMed ID: 27748735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].
    Larena A; Vierbuchen M; Schröder S; Larena-Avellaneda A; Hadshiew I; Fischer R
    Langenbecks Arch Chir; 1996; 381(2):102-13. PubMed ID: 8649124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers.
    Ikeda H; Harada K; Sato Y; Sasaki M; Yoneda N; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Am J Clin Pathol; 2013 Sep; 140(3):329-40. PubMed ID: 23955451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver.
    Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y
    Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tubulin β-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma.
    Zen Y; Britton D; Mitra V; Pike I; Sarker D; Itoh T; Heaton N; Quaglia A
    Histopathology; 2014 Dec; 65(6):784-92. PubMed ID: 25039376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholangiocarcinoma occurring in a liver with multiple bile duct hamartomas (von Meyenburg complexes).
    Röcken C; Pross M; Brucks U; Ridwelski K; Roessner A
    Arch Pathol Lab Med; 2000 Nov; 124(11):1704-6. PubMed ID: 11079031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic cholangiocarcinoma with predominant "ductal plate malformation" pattern: a new subtype.
    Nakanuma Y; Sato Y; Ikeda H; Harada K; Kobayashi M; Sano K; Uehara T; Yamamoto M; Ariizumi S; Park YN; Choi JH; Yu E
    Am J Surg Pathol; 2012 Nov; 36(11):1629-35. PubMed ID: 23073321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of mucin-producing cholangiocarcinoma.
    Matsuba H; Sakamoto Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):467. PubMed ID: 19553400
    [No Abstract]   [Full Text] [Related]  

  • 40. CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions.
    Gütgemann I; Haas S; Berg JP; Zhou H; Büttner R; Fischer HP
    Virchows Arch; 2006 Apr; 448(4):407-11. PubMed ID: 16411132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.